CRISPR/Cas9 System as an Agent for Eliminating Polyomavirus JC Infection

The CRISPR/Cas9 system inactivates latent HIV-1 proviral DNA

(2015) Weijun Zhu et al.   Retrovirology

Suppression of hepatitis B virus DNA accumulation in chronically infected cells using a bacterial CRISPR/Cas RNA-guided DNA endonuclease

(2015) Edward M. Kennedy et al.   VIROLOGY

Use of the CRISPR/Cas9 system as an intracellular defense against HIV-1 infection in human cells

(2015) Hsin-Kai Liao et al.   Nature Communications

In vitro and in vivo growth suppression of human papillomavirus 16-positive cervical cancer cells by CRISPR/Cas9

(2014) Shuai Zhen et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Development and Applications of CRISPR-Cas9 for Genome Engineering

(2014) Patrick D. Hsu et al.   CELL

Viruses and Human Cancers: a Long Road of Discovery of Molecular Paradigms

(2014) M. K. White et al.   CLINICAL MICROBIOLOGY REVIEWS

CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells

(2014) K.-S. Yuen et al.   JOURNAL OF GENERAL VIROLOGY

Inactivation of the Human Papillomavirus E6 or E7 Gene in Cervical Carcinoma Cells by Using a Bacterial CRISPR/Cas RNA-Guided Endonuclease

(2014) E. M. Kennedy et al.   JOURNAL OF VIROLOGY

RNA-guided endonuclease provides a therapeutic strategy to cure latent herpesviridae infection

(2014) J. Wang et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

RNA-directed gene editing specifically eradicates latent and prevents new HIV-1 infection

(2014) W. Hu et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The new frontier of genome engineering with CRISPR-Cas9

(2014) J. A. Doudna et al.   SCIENCE

The CRISPR/Cas9 System Facilitates Clearance of the Intrahepatic HBV Templates In Vivo

(2014) Su-Ru Lin et al.   Molecular Therapy-Nucleic Acids

Targeting Hepatitis B Virus With CRISPR/Cas9

(2014) Christoph Seeger et al.   Molecular Therapy-Nucleic Acids

Progressive Multifocal Leukoencephalopathy in Multiple Sclerosis

(2013) Joshua J. Chalkley et al.   Current Neurology and Neuroscience Reports

Cas9 as a versatile tool for engineering biology

(2013) Prashant Mali et al.   NATURE METHODS

Multiplex Genome Engineering Using CRISPR/Cas Systems

(2013) L. Cong et al.   SCIENCE

ZFN, TALEN, and CRISPR/Cas-based methods for genome engineering

(2013) Thomas Gaj et al.   TRENDS IN BIOTECHNOLOGY

Harnessing the CRISPR/Cas9 system to disrupt latent HIV-1 provirus

(2013) Hirotaka Ebina et al.   Scientific Reports

Progressive multifocal leukoencephalopathy developed 26 years after renal transplantation

(2012) Shigemi Nagayama et al.   CLINICAL NEUROLOGY AND NEUROSURGERY

Fatal PML associated with efalizumab therapy: Insights into integrin  L 2 in JC virus control

(2012) N. Schwab et al.   NEUROLOGY

Cooperative roles of NF-κB and NFAT4 in polyomavirus JC regulation at the KB control element

(2012) Hassen S. Wollebo et al.   VIROLOGY

CRISPR-Cas Systems in Bacteria and Archaea: Versatile Small RNAs for Adaptive Defense and Regulation

(2011) Devaki Bhaya et al.   Annual Review of Genetics

Rituximab-Associated Progressive Multifocal Leukoencephalopathy in Rheumatoid Arthritis

(2011) David B. Clifford   ARCHIVES OF NEUROLOGY

The clinical features of PML

(2011) J. R. BERGER   CLEVELAND CLINIC JOURNAL OF MEDICINE

Pathogenesis of Progressive Multifocal Leukoencephalopathy—Revisited

(2011) Martyn K. White et al.   JOURNAL OF INFECTIOUS DISEASES

Progressive multifocal leukoencephalopathy: clinical and molecular aspects

(2011) Eleonora Tavazzi et al.   REVIEWS IN MEDICAL VIROLOGY

Role for tumor necrosis factor-alpha in JC virus reactivation and progressive multifocal leukoencephalopathy

(2010) Hassen S. Wollebo et al.   JOURNAL OF NEUROIMMUNOLOGY

The regulation of cell proliferation by the papillomavirus early proteins

(2009) N. Abdul Hamid et al.   CELLULAR AND MOLECULAR LIFE SCIENCES

Gene Therapy Using Adeno-Associated Virus Vectors

(2008) S. Daya et al.   CLINICAL MICROBIOLOGY REVIEWS

Serotonin receptor 2A blocker (risperidone) has no effect on human polyomavirus JC infection of primary human fetal glial cells

(2008) Moti L Chapagain et al.   JOURNAL OF NEUROVIROLOGY